Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
3.100
-0.070 (-2.21%)
At close: Aug 13, 2025, 4:00 PM
3.100
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:00 AM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $531.87 million as of August 14, 2025. Its market cap has increased by 254.65% in one year.
Market Cap
531.87M
Enterprise Value
440.83M
1-Year Change
254.65%
Ranking
Category
Stock Price
$3.10
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $531.87M, an increase of 22.18%. That is a compound annual growth rate of 4.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 428.68M | 114.87% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |